Energy drinks pose health risks for small group of teenagers Of the more than 1.2 million Dutch young people between the ages of 13 and 18-years-old, 1 to 2 percent regularly drinks three or more cans of energy drinks per day.
Disease burden and cost-of-illness of food-related pathogens in the Netherlands Each year, RIVM presents an update on the number of illnesses caused by 14 enteric pathogens (such as Salmonella, Campylobacter or Listeria) that can be transmitted by food into the human body.
Rubber granulate on synthetic turf fields causes environmental impact Use of rubber granulate sourced from car tyres, on synthetic turf fields can be harmful to the environment in the close vicinity of these fields.
Animal-free innovations in safety assessment of chemicals How can the process of validation, acceptance and use of animal-free innovative approaches to assess the safety of chemicals be facilitated?
Rapid developments in modern biotechnology are a challenge for risk assessment Due to developments in modern biotechnology, such as genome editing, synthetic biology and regulation of gene expression, many new applications are expected in the next ten years.
Bacteriophages: insufficient understanding of phage treatment of human infections Bacteriophages are viruses that can kill bacteria. The question is whether bacteriophages can be used to treat infections in humans.
National Action Plan for sexual health The Dutch National Action Plan for STI, HIV and sexual health describes the most important goals for the next five years.
Greenhouse gas emissions slightly down in 2017 Despite the growth of the economy, greenhouse gas emissions in the Netherlands in 2017 were1 percent lower than in the previous year.
Addictive nicotine and harmful substances also present in heated tobacco Heated tobacco products are newly available on the market. An example of such a product is the heatstick which is heated with an iQOS, a device that looks like an e-cigarette.
Continued high effectiveness of vaccines against Hib disease A recent study by RIVM and AMC shows that the effectiveness of vaccination against Hib is still high.